Cronos Group | CRON - Sales Revenues

Stock Price
3.61
Daily Change
-0.15 -3.99%
Monthly
-1.90%
Yearly
21.14%
Q2 Forecast
3.53

Cronos Group reported $58.97M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Altria USD 4.76B 320M Mar/2026
Aurora Cannabis CAD 94.19M 3.82M Dec/2025
Boston Beer USD 433.9M 48.2M Mar/2026
British American Tobacco GBP 13.5B 1.43B Dec/2025
Canopy Growth CAD 74.54M 7.86M Dec/2025
Coca-Cola USD 12.5B 700M Mar/2026
Constellation Brands USD 2.22B 258.2M Sep/2025
Imperial Brands GBP 4.52B 13.05B Mar/2026
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Molson Coors Brewing USD 2.35B 310M Mar/2026
Monster Beverage USD 2.35B 218.95M Mar/2026
Organigram Holdings CAD 63.54M 16.52M Dec/2025
Philip Morris International USD 10.1B 300M Mar/2026
Tilray USD 217.51M 74.75M Dec/2025